EV71 Vaccine Consistency Study for Children
Part of Infections clinical trials.
This study tests three batches of an EV71 vaccine (which prevents hand, foot, and mouth disease) to see if they work the same. Your child would receive two doses, several weeks apart, and have blood tests to check their immune response.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 6 and 35 months old.
- Your child must not have a fever (underarm temperature below 99.1°F or 37.3°C) on the day of vaccination.
- Your child must not have received certain other vaccines recently (non-live vaccines in the past 7 days, live vaccines in the past 14 days).
- Your child must not have a history of severe allergies to vaccines or any ingredients in this vaccine (like aluminum or glycine).
- Your child must not have already received an EV71 (hand, foot, and mouth disease) vaccine before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how long immunity lasts after receiving two doses of the EV71 vaccine. It is for children who took part in the earlier study and got either the vaccine or a placebo.
This trial tests a vaccine that targets two viruses causing hand, foot, and mouth disease. It aims to see if the vaccine is safe and effective for people aged 6 months to 59 years.
This study tests an EV71 vaccine in healthy children aged 6 to 71 months. The vaccine aims to protect against hand, foot, and mouth disease caused by the EV71 virus.
This trial tests a new two-in-one vaccine to protect children against hand, foot, and mouth disease caused by two common viruses (EV71 and CA16). It is for healthy kids ages 6 months to 5 years and will check if the vaccine is safe and works well.
This study tests a new vaccine that protects against four types of enterovirus (EV71, CA16, CA10, CA6) that cause hand, foot, and mouth disease. Researchers want to see if the vaccine is safe and effective in young children ages 6 months to 6 years.
This trial tests two doses of a dengue vaccine in healthy infants and toddlers aged 6 to 21 months. It aims to see if the vaccine is safe and helps protect against dengue fever.
Hear when a new Hand, Foot and Mouth Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.